US-based Sciex Diagnostics has launched a new fully integrated LC-MS solution, Sciex Topaz System, for use in clinical diagnostics.

The system features the new ClearCore MD software designed to simplify and streamline workflows and method development, as well as increase usability to aid new users to quickly develop proficiency.

Providing flexibility for the clinical laboratories, Topaz comes with an open system for lab-developed tests (LDTs) and a closed system for locked pre-validated assays.

The LC-MS system further enables expansion of testing services by allowing the in-house use of tests that were previously outsourced, and better patient care with decreased time and complexity.

"The Topaz system empowers a lab to do more, save more, and deliver more confident results to support clinicians."

Sciex Diagnostics senior director and general manager Dr Aaron Hudson said: “Sciex set out with the goal to making mass spectrometry simple for clinical labs, and the outcome is the first integrated LC-MS-based IVD system that is open by design and closed when you need it.

“In conjunction with the first US Food and Drug Administration (FDA) cleared (via the de novo pathway) Vitamin D LC-MS assay, the Topaz system empowers a lab to do more, save more, and deliver more confident results to support clinicians.”

Sciex Vitamin D 200M Assay is developed to provide precise measurement of Vitamin D status by individually quantitating Vitamin D2 and D3, as well as simultaneously separating the D3 epimer.

The Vitamin D solution is available for immediate implementation with the Topaz System to facilitate quick use for laboratory staff.